Patents by Inventor Miyuki Anzai

Miyuki Anzai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9073885
    Abstract: A compound represented by the following Formula (1) that is effective for the treatment of Paget's disease of bone or hypercalcemia or a medically acceptable solvate thereof; [wherein R1 refers to hydrogen atom, C1-C6 alkyl group optionally substituted with hydrogen group or C1-C6 alkoxy group optionally substituted with hydroxyl group, R2a and R2b refer to hydrogen atom, C1-C10 alkyl group optionally substituted with hydroxyl group, C6-C10 aryl group optionally substituted with hydroxyl group or C7-C12 aralkyl group optionally substituted with a hydroxyl group, or are combined to represent ethylene group. However, a compound in which R1 is a hydrogen atom or a methyl group and R2a and R2b are hydrogen atoms is excluded].
    Type: Grant
    Filed: January 29, 2004
    Date of Patent: July 7, 2015
    Assignee: Teijin Pharma Limited
    Inventors: Kazuya Takenouchi, Miyuki Anzai, Hiroshi Saito, Kazuhisa Okada, Seiichi Ishizuka, Daishiro Miura, Hiroaki Takayama, Atsushi Kittaka, Nozomi Saito, Toshie Fujishima
  • Publication number: 20060148768
    Abstract: A compound represented by the following Formula (1) that is effective for the treatment of Paget's disease of bone or hypercalcemia or a medically acceptable solvate thereof; [wherein R1 refers to hydrogen atom, C1-C6 alkyl group optionally substituted with hydrogen group or C1-C6 alkoxy group optionally substituted with hydroxyl group, R2a and R2b refer to hydrogen atom, C1-C10 alkyl group optionally substituted with hydroxyl group, C6-C10 aryl group optionally substituted with hydroxyl group or C7-C12 aralkyl group optionally substituted with a hydroxyl group, or are combined to represent ethylene group. However, a compound in which R1 is a hydrogen atom or a methyl group and R2a and R2b are hydrogen atoms is excluded].
    Type: Application
    Filed: January 29, 2004
    Publication date: July 6, 2006
    Inventors: Kazuya Takenouchi, Miyuki Anzai, Hiroshi Saito, Kazuhisa Okada, Seiichi Ishizuka, Daishiro Miura, Hiroaki Takayama, Atsushi Kittaka, Nozomi Saito, Toshie Fujishima
  • Publication number: 20050101575
    Abstract: A vitamin D3 derivative expressed by the following general formula (1) [wherein, R is a hydrogen atom or a methyl group, and A is a single bond, —CH2—, —CH?CH—, —CH2—CH?CH—, —CH?CH—CH?CH—, —C?C— or —CH2—C?C—; and a compound in which R is an hydrogen atom, A is —CH2—, the steric configuration at the 1-position is (S)-configuration, and the steric configuration at the 3-position is (R)-configuration is excluded] or a pharmaceutically permissible solvate thereof. The compound can be an effective ingredient of a treating agent for osteoporosis, malignant tumor, psoriasis, hyperparathyroidism, an inflammatory respiratory disease, rheumatoid arthritis, growth onset type diabetes mellitus, hypertension, alopecia, acne, dermatitis, hypercalcemia or Paget's disease of bone.
    Type: Application
    Filed: February 19, 2003
    Publication date: May 12, 2005
    Inventors: Karuya Takenouchi, Miyuki Anzai, Kenji Manabe, Seiichi Ishizuka, Daishiro Miura